Diabetes-related thrombotic risk factors include: Hyperglycaemia-induced endothelial dysfunction , promoting a prothrombotic state Increased platelet reactivity and aggregation Elevated levels of clotting factors including fibrinogen and von Willebrand factor Chronic inflammation with raised inflammatory markers Impaired fibrinolysis , reducing the body's ability to break down clots Obesity independently increases thrombotic risk through multiple mechanisms
Children: The recommended maintenance dose is 3 mg once daily
Parmi les effets indsirables les plus courants, on retrouve des troubles gastro-intestinaux tels que nauses, vomissements, diarrhes ou encore des douleurs abdominales, souvent observs au dbut du traitement
Der Duft ist angenehm und die Haut fhlt sich den ganzen Tag geschmeidig an
The Novo Nordisk prospect has been shown to normalize body weight in obese mice
6 This represents over 40% of the combined D-SNP/MMP enrollment in California and over 25% of the nationwide MMP enrollment